Immunonutritional status, assessed by PNI and SII, significantly influences ovarian cancer prognosis, affecting survival outcomes and chemotherapy tolerance. High PNI and low SII correlate with longer ...

Researchers have developed a new prediction tool that could help clinicians better assess whether complete tumour removal is ...

Although frontline maintenance treatment with fuzuloparib monotherapy produced a progression-free survival (PFS) benefit in patients with newly diagnosed advanced ovarian cancer, the addition of ...

The optimal timing of surgery in patients with resectable advanced ovarian cancer remains controversial. Should these patients receive the standard radical surgery followed by chemotherapy, or could ...

Terri Baker was diagnosed with stage 4 ovarian cancer in September. Today, the cancer is undetectable. When Terri Baker walked into an emergency room for blood in her urine, doctors diagnosed her with ...

ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...

Long-Term Follow-Up of Real-World Adjuvant Anti–PD-1 Checkpoint Inhibition and Targeted Therapy in Patients With Stage III Melanoma In this phase II, open-label study, patients with recurrent, ...

Women with an inherited risk of developing ovarian cancer because they have the so-called Angelina Jolie gene alteration can now be tested on the NHS thanks to UCL research. University College London ...